Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled date : 2022 - 03 - 09 save search
Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
PALI | $6.39 7.94% 7.36% 460K
|
Manufacturing
|
| O: 0.01%
H: 11.63%
C: 10.44%
lb1148 america gastrointestinal nasdaq test
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
XXII 4 | $1.845 10.48% 9.49% 1M
|
Health Technology
|
| O: 3.23%
H: 3.35%
C: 1.34%
conference nasdaq group
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at the American Association for Cancer Research Annual Meeting
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 2.71%
H: 5.58%
C: 4.56%
america health blood research test cancer
I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: 4.24%
H: 3.69%
C: 2.92%
america research presentation cancer
TE Connectivity announces approval of quarterly dividends by shareholders at 2022 Annual General Meeting
Published: 2022-03-09 (Crawled : 22:00) - prnewswire.com
TEL | News | $140.0 -2.26% 0.0% 5.8M
|
Electronic Technology
|
| O: -1.48%
H: 2.04%
C: 1.39%
approval
Portage Biotech Announces Presentation of PORT-5 (STI-001) Late-Breaking Data at AACR 2022 Annual Meeting
Published: 2022-03-09 (Crawled : 21:00) - biospace.com/
PRTG | $0.265 9.23% 8.45% 180K
|
Mining, Quarrying, and Oil and ...
|
| O: 4.71%
H: 5.98%
C: -0.12%
sti-001 ces presentation biotech iot
Prelude Therapeutics Provides Clinical Update and Announces Presentation of New Preclinical Data at the Upcoming 2022 AACR Annual Meeting
Published: 2022-03-09 (Crawled : 13:30) - globenewswire.com
PRLD | $3.91 1.03% 1.02% 29K
|
Health Technology
|
| O: 4.33%
H: 8.53%
C: 4.86%
therapeutics presentation preclinical pre-clinical
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 13:30) - globenewswire.com
STTK | $9.87 4.0% 3.85% 230K
|
Health Technology
|
| O: 0.0%
H: 1.07%
C: 0.85%
america pos research cancer
IMV to Showcase its DPX® Delivery Technology in Two Presentations at the AACR Annual Meeting 2022
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 1.69%
H: 0.0%
C: 0.0%
dpx technology liver presentation
Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting
Published: 2022-03-09 (Crawled : 13:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 8.72%
H: 1.23%
C: -1.85%
biotech pos ces presentation iot
Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting
Published: 2022-03-09 (Crawled : 13:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 8.72%
H: 1.23%
C: -1.85%
biotech phase 1b phase 1 roof iot phase 2b
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-09 (Crawled : 12:00) - globenewswire.com
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 4.35%
H: 4.83%
C: 4.0%
sm-88 america pos research cancer
Notice of annual general meeting of H+H International A/S
Published: 2022-03-09 (Crawled : 11:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.32%
H: 7.71%
C: 5.4%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 3.16%
H: 3.23%
C: 2.95%
Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 02:00) - globenewswire.com
CRBU | $3.86 -3.02% -3.11% 1.1M
|
Health Technology
|
| O: 4.28%
H: 5.05%
C: 2.74%
cb-011 america car-t research cel preclinical therapy bioscience cancer t-cell pre-clinical
Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting– Presentations to highlight significant opportunities targeting farnesyl transferase inhibition –
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
KURA | News | $18.76 0.16% 0.16% 670K
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
ces presentation
Xencor to Present Preclinical Data from XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
xmab america program research preclinical cancer pre-clinical
Alpine Immune Sciences Announces Oral Presentation at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
ALPN | $64.57 0.03% 0.03% 1.2M
|
Health Technology
|
| O: 2.94%
H: 0.0%
C: 0.0%
presentation
Repare Therapeutics to Present Comprehensive Phase 1 Monotherapy Data From the Phase 1/2 TRESR RP-3500 Clinical Trial and SNiPDx Panel at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
RPTX 4 | $3.3 -1.79% -1.82% 73K
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
rp-3500 500 trial therapeutics phase 1 therapy phase 2 phase 3
Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
EXAI | $4.15 -5.25% -5.54% 360K
|
|
| O: 0.0%
H: 14.63%
C: 12.76%
america research cancer platform
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
CNTX | $1.38 -2.13% -2.17% 37K
|
Health Technology
|
| O: 3.21%
H: 7.21%
C: 6.21%
therapeutics america ces research cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.